3 Conclusion The troubling rise in the number of subjects affected by obesity worldwide has necessitated new scientific developments to blunt previous adverse effects of medication and facilitate administration, addressing different problems with a single drug
However, during clinical trials, researchers noticed that people taking topiramate lost some weight
Additionally, the surge in people using them for treating obesity has caused a supply shortage
The move signals that OFA is not banking solely on summary judgment in the lower court and instead sees an opportunity to challenge the legal framework the FDA used to justify its crackdown on compounding
Similar content being viewed by others Main T2D is responsible for an average two-fold-higher risk for cardiovascular events, such as coronary heart disease, ischemic stroke, hospitalization for heart failure (HHF) and vascular death, independent of other established risk factors 1,2